NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-129-2022-0-US-01 CD25-SPECIFIC ANTIBODIES AND USES THEREOF US 63/357,215 Expired
NIAID E-197-2023-1-US-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US 63/357,331 Expired
NCI E-199-2023-0-PC-01 TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA PCT PCT PCT/EP2022/068204 Expired
NIAID E-297-2016-2-US-09 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US CON 17/851,905 12054519 Issued PDF
NCATS E-074-2019-0-US-06 METHOD FOR INHIBITING DENGUE VIRUS INFECTION US CON 17/809,327 11903929 Issued PDF
NCATS E-074-2019-0-US-07 METHOD FOR INHIBITING ZIKA VIRUS INFECTION US CON 17/809,353 11878004 Issued PDF
NCATS E-074-2019-0-US-05 METHOD FOR INHIBITING ZIKA VIRUS INFECTION US CON 17/809,339 11850236 Issued PDF
NCATS E-074-2019-0-US-04 METHOD FOR INHIBITING DENGUE VIRUS INFECTION US CON 17/809,345 11779570 Issued PDF
NIDCR E-186-2019-0-US-05 TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH US National Stage 17/789,742 Pending
NEI E-008-2020-0-US-03 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES US National Stage 17/789,729 Pending
NCI E-114-2011-0-US-06 METHODS OF GROWING TUMOR INFILTRATING LYMPHOCYTES IN GAS-PERMEABLE CONTAINERS US CON 17/851,173 Abandoned
NIAID E-004-2009-2-US-28 VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE US DIV 17/850,706 11992523 Issued PDF
NCI E-106-2017-0-US-04 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS US CON 17/849,951 Abandoned
NLM E-111-2016-9-US-02 NOVEL CRISPR ENZYMES AND SYSTEMS US DIV 17/848,563 11773412 Issued PDF
NCI E-229-2014-0-JP-13 METHODS FOR ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR CANCER SPECIFIC MUTATIONS JP DIV 2022-101099 Issued
NHLBI E-091-2021-0-PCT-02 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE PCT PCT PCT/US2022/034511 Expired
NCATS E-244-2014-0-HK-33 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof HK EP 42022055599.9 Pending
NIAID E-060-2015-0-IL-19 Novel Multivalent Nanoparticle-Based Vaccines IL DIV 294189 Pending
NCI E-174-2018-2-GB-19 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY GB DIV 2209032.8 Issued
NCI E-105-2019-0-US-08 CD206 Modulators Their Use and Methods for Preparation US National Stage 17/787,313 Pending
NCI E-023-2019-0-EP-04 INHIBITORS OF HISTONE DEMETHYLASES EP National Stage 20824760.1 Pending
NIAID E-001-2024-0-US-01 Viral Strain Serology Assays US 63/353,225 Expired
NIAID E-216-2021-0-PCT-02 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery PCT PCT PCT/US2022/033819 Expired
NIAID E-216-2021-0-TW-04 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery TW ORD 111122464 Pending
NIAID E-153-2019-1-NZ-11 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE NZ National Stage 789242 Pending
NCI E-094-2017-0-AU-01 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment AU DIV 2022204182 Issued
NCI E-205-2010-2-US-22 PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES US CON 17/841,110 Pending
CC E-183-2016-0-HK-18 DETECTION OF PROSTATE CANCER IN MULTI-PARAMETRIC MRI USING RANDOM FOREST WITH INSTANCE WEIGHTING & MR PROSTATE SEGMENTATION BY DEEP LEARNING WITH HOLISTICALLY-NESTED NETWORKS HK EP 42022055182.4 Pending
NIAAA E-110-2022-0-US-01 METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES US 63/352,428 Expired
NIDDK E-127-2019-0-US-04 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION US National Stage 17/785,155 Pending
NIAID E-133-2015-0-CN-12 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE CN DIV 202210669835.0 Pending
NCI E-494-2013-0-US-29 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 17/838,662 11918640 Issued PDF
NHLBI E-155-2016-0-US-05 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US CON 17/839,264 Abandoned
NCATS E-041-2021-2-US-01 RALDH1 Inhibitors For The Immunotherapy Of Hepatocellular Carcinoma US 63/351,624 Abandoned
NIAID E-153-2019-1-US-13 Recombinant Prefusion Measles And Mumps F And F-HN Glycoproteins And Their Use US National Stage 17/784,605 Pending
NCI E-123-2020-0-US-01 FIRST SARS-COV-2 VACCINE IMMUNOGENS US 63/351,196 Expired
NCI E-148-2021-0-PCT-02 COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER PCT PCT PCT/US2022/032917 Expired
NCI E-003-2020-0-US-08 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY US National Stage 17/783,866 Pending
NCATS E-156-2022-0-US-01 COMPOUNDS FOR INHIBITING GRAM-POSITIVE BACTERIA US 63/350,533 Expired
NHLBI E-111-2022-0-US-01 REAL-TIME ARTIFICIAL INTELLIGENCE FOR OPEN-WORLD AND EXPLAINABLE ECHOCARDIOGRAPHY ANALYSIS AND QUANTIFICATION US 63/350,720 Expired
NCI E-106-2021-0-PCT-02 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2022/032798 Expired
NCI E-234-2014-1-JP-02 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF JP DIV 2022-092616 Issued
NHLBI E-025-2019-0-US-03 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF US National Stage 17/783,345 Pending
NCI E-121-2022-0-US-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR DELIVERY OF THERAPEUTICS US 63/350,315 Expired
NCI E-021-2015-0-JP-37 Anti-CD70 Chimeric Antigen Receptors JP DIV 2022-092594 Issued
NCI E-145-2019-0-US-07 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF US National Stage 17/783,171 Pending
NCI E-028-2015-1-HK-43 Anti-Mutated Kras T Cell Receptors HK CN 42022054674.1 Pending
NCI E-186-2022-0-US-01 PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES US 63/349,829 Expired
NIDDK E-160-2022-0-US-01 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY US 63/349,626 Expired
NCI E-055-2011-0-US-13 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE US DIV 17/833,383 Pending